Science and technology of nanomaterials: current status and future prospects

The science and technology of nanomaterials has created great excitement and expectations in the last few years. By its very nature, the subject is of immense academic interest, having to do with very tiny objects in the nanometer regime. There has already been much progress in the synthesis, assembly and fabrication of nanomaterials, and, equally importantly, in the potential applications of these materials in a wide variety of technologies. The next decade is likely to witness major strides in the preparation, characterization and exploitation of nanoparticles, nanotubes and other nanounits, and their assemblies. In addition, there will be progress in the discovery and commercialization of nanotechnologies and devices. These new technologies are bound to have an impact on the chemical, energy, electronics and space industries. They will also have applications in medicine and health care, drug and gene delivery being important areas. This article examines the important facets of nanomaterials research, highlighting the current trends and future directions. Since synthesis, structure, properties and simulation are important ingredients of nanoscience, materials chemists have a major role to play

Open-framework zinc and cobalt phosphates synthesized by the tributylphosphate route

By employing tributylphosphate as the source of phosphorus, several open-framework zinc and cobalt phosphates have been prepared hydrothermally. Of the three new zinc phosphates [C6N2H18][Zn(HPO4)2], I, has a linear chain structure while [C4N2H14][Zn5(PO4)4(H2O)], II, [NH4][H3O][Zn4(PO4)3]2·H2O, III, have three-dimensional structures. Of the three new cobalt phosphates described, [C5N2H14][Co(HPO4)2], IV, and [C5N2H14][Co(HPO4)2], V, have linear chain structures, while [C4N2H12]3 [Co2(OH)(HPO4)3]2, VI, has a complex double chain structure. The study shows that the use of the organophosphate yields a variety of architectures of metal phosphates

Optical Studies of Er-doped Yttrium Aluminium Garnet Phosphor Materials

The need for materials application in solid-state lasers, medical devices, and optoelectronic devices has made the investigation of ceramic materials of increasing importance. A detail study of the optical properties of rare earth element typically from luminescent materials when intentionally doped inside the host materials and in particular crystal (such as YAG) is reported for the photoluminescence, power and lifetime measurement. The rare-earth dopants usually form trivalent lanthanide ions and the energy transfer and optical transitions involved originate from 4f-4f transitions of the ions and between these states and the host material. In order to understand the energy transfer processes in more detail we need to better understand the accompanying optical processes that give rise to the emission they display and it is this that forms the focus of the work presented. Following this second (and higher) order processes are considered that lead to upconversion in erbium-doped yttrium aluminum garnet (Er:YAG) materials

A longitudinal, observational study examining the relationships of patient satisfaction with services and mental well-being to their clinical course in young people with Type 1 diabetes mellitus during transition from child to adult health services

AIM: We hypothesized that participant well-being and satisfaction with services would be positively associated with a satisfactory clinical course during transition from child to adult health care. METHODS: Some 150 young people with Type 1 diabetes mellitus from five diabetes units in England were recruited to a longitudinal study of transition. Each young person was visited at home four times by a research assistant; each visit was 1 year apart. Satisfaction with services (Mind the Gap; MTG) and mental well-being (Warwick-Edinburgh Mental Well-being Scale; WEMWBS) were captured. Change in HbA1c , episodes of ketoacidosis, clinic and retinal screening attendance were used to assess clinical course. In total, 108 of 150 (72%) young people had sufficient data for analysis at visit 4. RESULTS: Mean age at entry was 16 years. By visit 4, 81.5% had left paediatric healthcare services. Median HbA1c increased significantly (P = 0.01) from 69 mmol/mol (8.5%) at baseline to 75 mmol/mol (9.0%) at visit 4. WEMWBS scores were comparable with those in the general population at baseline and were stable over the study period. MTG scores were also stable. By visit 4, some 32 individuals had a 'satisfactory' and 76 a 'suboptimal' clinical course. There were no significant differences in average WEMWBS and MTG scores between the clinical course groups (P = 0.96, 0.52 respectively); nor was there a significant difference in transfer status between the clinical course groups. CONCLUSIONS: The well-being of young people with diabetes and their satisfaction with transition services are not closely related to their clinical course. Investigating whether innovative psycho-educational interventions can improve the clinical course is a research priority

A new route for the synthesis of open-framework metal phosphates using organophosphates

Use of tributylphosphate, an organophosphate, as the phosphorus source in place of phosphoric acid, has enabled the synthesis of several new open-framework zinc(II) and cobalt(II) phosphates, under solvothermal conditions

Electrical properties of inorganic nanowire-polymer composites

Composites of nanowires of ZnO, RuO2 and Ag with polyaniline (PANI) as well as polypyrrole (PPy) have been prepared, for the first time, by an in-situ process, in order to investigate their electrical properties. Characterization by electron microscopy and IR spectroscopy indicates that there is considerable interaction between the oxide nanowires and the polymer. The room-temperature resistivity of the composites prepared in-situ varies in the 0.01-400 Ω cm range depending on the composition. While the resistivities of the PANI-ZnONW and PPy-ZnONW composites prepared by the in-situ process are generally higher than that of PANI/PPy, those of PANI-RuO2NW and PANI-AgNW are lower. Composites of ZnONW with polyaniline prepared by an ex-situ process exhibit a resistivity close to that of polyaniline

Graphene-wrapped sulfur/metal organic framework-derived microporous carbon composite for lithium sulfur batteries

A three-dimensional hierarchical sandwich-type graphene sheet-sulfur/carbon (GS-S/CZIF8-D) composite for use in a cathode for a lithium sulfur (Li-S) battery has been prepared by an ultrasonic method. The microporous carbon host was prepared by a one-step pyrolysis of Zeolitic Imidazolate Framework-8 (ZIF-8), a typical zinc-containing metal organic framework (MOF), which offers a tunable porous structure into which electro-active sulfur can be diffused. The thin graphene sheet, wrapped around the sulfur/zeolitic imidazolate framework-8 derived carbon (S/CZIF8-D) composite, has excellent electrical conductivity and mechanical flexibility, thus facilitating rapid electron transport and accommodating the changes in volume of the sulfur electrode. Compared with the S/CZIF8-D sample, Li-S batteries with the GS-S/CZIF8-D composite cathode showed enhanced capacity, improved electrochemical stability, and relatively high columbic efficiency by taking advantage of the synergistic effects of the microporous carbon from ZIF-8 and a highly interconnected graphene network. Our results demonstrate that a porous MOF-derived scaffold with a wrapped graphene conductive network structure is a potentially efficient design for a battery electrode that can meet the challenge arising from low conductivity and volume change.National Science Foundation of China (21373028)This is the final version of the article. It first appeared from American Institute of Physics Publishing via http://dx.doi.org/10.1063/1.490175

Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs.

Inherited retinal dystrophies are an important cause of blindness, for which currently there are no effective treatments. In order to study this heterogeneous group of diseases, adequate disease models are required in order to better understand pathology and to test potential therapies. Induced pluripotent stem cells offer a new way to recapitulate patient specific diseases in vitro, providing an almost limitless amount of material to study. We used fibroblast-derived induced pluripotent stem cells to generate retinal pigment epithelium (RPE) from an individual suffering from retinitis pigmentosa associated with biallelic variants in MERTK. MERTK has an essential role in phagocytosis, one of the major functions of the RPE. The MERTK deficiency in this individual results from a nonsense variant and so the MERTK-RPE cells were subsequently treated with two translational readthrough inducing drugs (G418 & PTC124) to investigate potential restoration of expression of the affected gene and production of a full-length protein. The data show that PTC124 was able to reinstate phagocytosis of labeled photoreceptor outer segments at a reduced, but significant level. These findings represent a confirmation of the usefulness of iPSC derived disease specific models in investigating the pathogenesis and screening potential treatments for these rare blinding disorders

Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells

Autosomal dominant optic atrophy (DOA) is the most common inherited optic neuropathy, characterised by the preferential loss of retinal ganglion cells (RGCs), resulting in optic nerve degeneration and progressive bilateral central vision loss. Over 60% of genetically confirmed DOA patients carry variants in the nuclear OPA1 gene, which encodes for a ubiquitously expressed, mitochondrial GTPase protein. OPA1 has diverse functions within the mitochondrial network, facilitating inner membrane fusion and cristae modelling, regulating mitochondrial DNA maintenance and coordinating mitochondrial bioenergetics. There are currently no licensed disease-modifying therapies for DOA and the disease mechanisms driving RGC degeneration are poorly understood. Here, we describe the generation of isogenic, heterozygous OPA1 null iPSC (OPA1+/-) through CRISPR/Cas9 gene editing of a control cell line, in conjunction with the generation of DOA patient-derived iPSC carrying OPA1 variants, namely, the c.2708_2711delTTAG variant (DOA iPSC), and previously reported missense variant iPSC line (c.1334G>A, DOA+ iPSC) and CRISPR/Cas9 corrected controls. A two-dimensional (2D) differentiation protocol was used to study the effect of OPA1 variants on iPSC-RGC differentiation and mitochondrial function. OPA1+/-, DOA and DOA+ iPSC showed no differentiation deficit compared to control iPSC lines, exhibiting comparable expression of all relevant markers at each stage of differentiation. OPA1+/- and OPA1 variant iPSC-RGCs exhibited impaired mitochondrial homeostasis, with reduced bioenergetic output and compromised mitochondrial DNA maintenance. These data highlight mitochondrial deficits associated with OPA1 dysfunction in human iPSC-RGCs, and establish a platform to study disease mechanisms that contribute to RGC loss in DOA, as well as potential therapeutic interventions